Skip to content
OpenCapital
Get started

Establishment Labs ESTA Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value at other companies

Globus Medical logo
Globus MedicalGMED
——

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio3×-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Establishment Labs (ESTA) reported share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value of $19.61M in Q1 2026.
How has Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value changed year-over-year?
Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value increased by 61.0% year-over-year, from $12.18M to $19.61M.
What is the long-term trend for Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value?
Over 5 years (2020 to 2025), Establishment Labs's share-based compensation arrangement by share-based payment award, options, outstanding, intrinsic value has grown at a -3.1% compound annual growth rate (CAGR), from $42.13M to $35.9M.